Literature DB >> 20614390

Disseminated intravascular coagulation in trauma injuries.

Giuseppe Lippi1, Gianfranco Cervellin.   

Abstract

Physical injuries, especially road traffic injuries, are a leading cause of death and morbidity worldwide, ranking fifth among the leading causes of death in the United States. Immediate and early trauma deaths are mainly determined by primary brain injuries and/or hemorrhages, whereas late mortality is caused by secondary brain injuries, host defense failure, and superimposed complications including also disseminated intravascular coagulation (DIC). Trauma patients are particularly susceptible to the early development of coagulopathy, and the most severely injured patients are coagulopathic on hospital admission. The zenith of the problem is typically seen in patients with head injuries and in those who are massively injured and transfused. The resulting coagulopathy is characterized by nonsurgical bleeding from mucosal lesions, serosal surfaces, and wound and vascular access sites. DIC associated with traumatic injury results from multiple independent but interplaying mechanisms, involving tissue trauma, shock, and inflammation. As such, the multifaceted derangement of hemostasis occurring after massive traumatic injuries, especially those involving the brain, is mainly sustained by release of procoagulants (fats, phospholipids) and constitutive tissue factor from the injured tissue into the circulation, associated with a systemic inflammatory response that also promotes tissue factor hyperexpression on monocytes and the other cells. The excessive, non-wound-related thrombin generation is insufficiently antagonized by physiological anticoagulant pathways and amplified by impaired endogenous fibrinolysis. The resulting burst of systemic thrombin generation, coupled with platelet hyperaggregability, shock, hypothermia, and tissue hypoperfusion, further contribute to the development of DIC and microvascular bleeding. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20614390     DOI: 10.1055/s-0030-1254047

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  5 in total

Review 1.  Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation.

Authors:  Florian Langer; Wolfram Ruf
Journal:  Thromb Haemost       Date:  2014-01-23       Impact factor: 5.249

Review 2.  Ten Rules for the Management of Moderate and Severe Traumatic Brain Injury During Pregnancy: An Expert Viewpoint.

Authors:  Simone Di Filippo; Daniel Agustin Godoy; Marina Manca; Camilla Paolessi; Federico Bilotta; Ainhoa Meseguer; Paolo Severgnini; Paolo Pelosi; Rafael Badenes; Chiara Robba
Journal:  Front Neurol       Date:  2022-06-09       Impact factor: 4.086

3.  Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity.

Authors:  Anna N Ilinskaya; Sonny Man; Anil K Patri; Jeffrey D Clogston; Rachael M Crist; Raul E Cachau; Scott E McNeil; Marina A Dobrovolskaia
Journal:  Nanomedicine (Lond)       Date:  2013-11-27       Impact factor: 5.307

4.  Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness.

Authors:  William E Plautz; Zachary A Matthay; Marian A Rollins-Raval; Jay S Raval; Lucy Z Kornblith; Matthew D Neal
Journal:  Transfusion       Date:  2020-06-01       Impact factor: 3.157

5.  The influence of hemocoagulation disorders on the development of posttraumatic cerebral infarction and outcome in patients with moderate or severe head trauma.

Authors:  Hao Chen; Li-Xia Xue; Yan Guo; Shi-Wen Chen; Gan Wang; He-Li Cao; Jiong Chen; Heng-Li Tian
Journal:  Biomed Res Int       Date:  2013-08-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.